BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18434015)

  • 41. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.
    Zheng C; Ren Z; Wang H; Zhang W; Kalvakolanu DV; Tian Z; Xiao W
    Cancer Res; 2009 Mar; 69(6):2324-31. PubMed ID: 19276347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasoactive intestinal peptide-induced neuritogenesis in neuroblastoma SH-SY5Y cells involves SNAP-25.
    Héraud C; Chevrier L; Meunier AC; Muller JM; Chadéneau C
    Neuropeptides; 2008; 42(5-6):611-21. PubMed ID: 18617262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells.
    Gentilella A; Passiatore G; Deshmane S; Turco MC; Khalili K
    Oncogene; 2008 Aug; 27(37):5011-8. PubMed ID: 18469860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytoprotective effect of polypeptide from Chlamys farreri on neuroblastoma (SH-SY5Y) cells following HO exposure involves scavenging ROS and inhibition JNK phosphorylation.
    Ye J; Han Y; Wang C; Yu W
    J Neurochem; 2009 Oct; 111(2):441-51. PubMed ID: 19682211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glutathione S-transferase pi regulates UV-induced JNK signaling in SH-SY5Y neuroblastoma cells.
    Castro-Caldas M; Milagre I; Rodrigues E; Gama MJ
    Neurosci Lett; 2009 Feb; 451(3):241-5. PubMed ID: 19159663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythropoietin receptor-mediated Egr-1 activation: structural requirements and functional implications.
    Schulze C; Büchse T; Mikkat S; Bittorf T
    Cell Signal; 2008 Oct; 20(10):1848-54. PubMed ID: 18627790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway.
    Lin X; Wang YJ; Li Q; Hou YY; Hong MH; Cao YL; Chi ZQ; Liu JG
    FEBS J; 2009 Apr; 276(7):2022-36. PubMed ID: 19292871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene expression and cell growth are modified by silencing SUMO2 and SUMO3 expression.
    Yang W; Paschen W
    Biochem Biophys Res Commun; 2009 Apr; 382(1):215-8. PubMed ID: 19275883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells.
    Ojala JO; Sutinen EM; Salminen A; Pirttilä T
    J Neuroimmunol; 2008 Dec; 205(1-2):86-93. PubMed ID: 18947885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ELK-1 ubiquitination status and transcriptional activity are modulated independently of F-Box protein FBXO25.
    Quintero-Barceinas RS; Gehringer F; Ducker C; Saxton J; Shaw PE
    J Biol Chem; 2021; 296():100214. PubMed ID: 33428929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional dysregulation in Down syndrome: predictions for altered protein complex stoichiometries and post-translational modifications, and consequences for learning/behavior genes ELK, CREB, and the estrogen and glucocorticoid receptors.
    Gardiner K
    Behav Genet; 2006 May; 36(3):439-53. PubMed ID: 16502135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1.
    Yang SH; Sharrocks AD
    Biochem Soc Symp; 2006; (73):121-9. PubMed ID: 16626293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ETS-Domain Transcription Factor Elk-1 Regulates Stemness Genes in Brain Tumors and CD133+ BrainTumor-Initiating Cells.
    Sogut MS; Venugopal C; Kandemir B; Dag U; Mahendram S; Singh S; Gulfidan G; Arga KY; Yilmaz B; Kurnaz IA
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elk-1 interacts with dynein upon serum stimulation but independent of serine 383 phosphorylation.
    Demir O; Ari O; Kurnaz IA
    Cell Mol Neurobiol; 2012 Mar; 32(2):185-9. PubMed ID: 21935709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. De-ubiquitination of ELK-1 by USP17 potentiates mitogenic gene expression and cell proliferation.
    Ducker C; Chow LKY; Saxton J; Handwerger J; McGregor A; Strahl T; Layfield R; Shaw PE
    Nucleic Acids Res; 2019 May; 47(9):4495-4508. PubMed ID: 30854565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Signal-dependent Elk-1 target genes involved in transcript processing and cell migration.
    Kasza A
    Biochim Biophys Acta; 2013 Oct; 1829(10):1026-33. PubMed ID: 23711433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brucellosis In Bison, Elk, and Moose In Elk Island National Park, Alberta, Canada.
    Corner AH; Connell R
    Can J Comp Med Vet Sci; 1958 Jan; 22(1):9-21. PubMed ID: 17649021
    [No Abstract]   [Full Text] [Related]  

  • 59. Personal Observation In The Care And Management Of An Elk (Wapiti) Herd At Elk Island Park, Alberta, Canada.
    Love BI
    Can J Comp Med Vet Sci; 1955 Jun; 19(6):184-92. PubMed ID: 17648823
    [No Abstract]   [Full Text] [Related]  

  • 60. Correction: MZF-1/Elk-1 Complex Binds to Protein Kinase Cα Promoter and Is Involved in Hepatocellular Carcinoma.
    Yue CH; Huang CY; Tsai JH; Hsu CW; Hsieh YH; Lin H; Liu JY
    PLoS One; 2015; 10(6):e0131036. PubMed ID: 26076018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.